(1)
Molecular Docking Studies FDA Approved Quercetin Inhibitory Potential of ATP Synthase F0F1 Subunit Beta from Streptococcus Mutans. Multidisciplinary, Scientific Work and Management Journal 2026, 36 (2), 1394-1397. https://doi.org/10.7492/xadsj448.